← Back to Clinical Trials
Recruiting NCT07489742
NCT07489742 Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT07489742 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Ondansetron |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2026-03-25 |
| Primary Completion | 2026-09-01 |
Trial Parameters
Condition Ondansetron
Sponsor Tanta University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 210
Sex ALL
Min Age 4 Years
Max Age 15 Years
Start Date 2026-03-25
Completion 2026-09-01
All Conditions
Interventions
Ondansetron lozengeOndansetron intravenous
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in tonsillectomy.
Eligibility Criteria
Inclusion Criteria: * Age from 4 to 15 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. * Children undergoing tonsillectomy under general anesthesia. Exclusion Criteria: * Allergy to ondansetron. * History of sleep apnea. * Cardiac and respiratory diseases. * Upper respiratory tract infection. * Taking corticosteroids.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology